Advertisement
Product › Details
ImuLyme®
Status | 1999-07-26 development existent | |
Record changed: 2023-07-10 |
Advertisement
More documents for vaccine_o
- [1] Valneva S.E.. (11/10/23). "Press Release: Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain....
- [2] Valneva S.E.. (11/9/23). "Press Release: Valneva Reports Nine-Month 2023 Financial Results and Provides Corporate Updates". Saint Herblain....
- [3] Valneva S.E.. (9/25/23). "Press Release: Valneva Announces New Ixiaro Supply Contract with the U.S. Government Worth a Minimum of $32 Million". Saint Herblain....
- [4] Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain....
- [5] Valneva S.E.. (8/18/22). "Press Release: Valneva Provides Update on Ixiaro Supply Contract with U.S. Department of Defense". Saint-Herblain....
- [6] GSK plc. (5/31/22). "Press Release: GSK to Acquire Clinical-stage Biopharmaceutical Company Affinivax, Inc.". London....
- [7] Valneva S.E.. (9/3/21). "Press Release: Valneva – U.S. DoD Exercises First Year Option on Ixiaro Supply Contract". Saint-Herblain....
- [8] Valneva S.E.. (9/9/20). "Press Release: Valneva Announces New Ixiaro Supply Contract with the US Government Worth up to $166 Million". Saint-Herblain....
- [9] Valneva S.E.. (9/8/20). "Press Release: Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate VLA1553". Saint-Herblain....
- [10] Valneva S.E.. (6/18/20). "Press Release: Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership". Saint-Herblain....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top